期刊
JOURNAL OF HOSPITAL INFECTION
卷 122, 期 -, 页码 140-147出版社
W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2022.01.010
关键词
C. difficile; Sporicidal activity; Suspension test; 4-field test; Peracetic acid; Glutaraldehyde
资金
- Association for Applied Hygiene (VAH), Bonn, Germany
The study compared the efficacy of five 'sporicidal' surface disinfectants against C. difficile spores, with products A, C, and D showing good sporicidal effects in suspension and on surfaces, while products B and E demonstrated less effectiveness.
Background: A sporicidal surface disinfection is recommended both for the outbreak and the endemic setting but a comparative evaluation on the efficacy of 'sporicidal' surface disinfectants using suspension tests and 4-field tests has not been performed. Aim: To determine the efficacy of five 'sporicidal' surface disinfectants (three ready-touse wipes (A, B, E), two concentrates (C, D) based on peroxides or aldehydes against C. difficile spores. Methods: The efficacy was determined under clean conditions using a suspension test and the 4-field test. Each test was performed in duplicate in two separate laboratories. Wipes were wrung to collect the solution for the suspension tests. Results: Product A (peracetic acid; 5 min), product C (peracetic acid; 2% solution in 15 min or 1% solution in 30 min) and product D (peracetic acid; only 2% solution in 15 min) were effective with at least a 4 log(10)-reduction of C. difficile spores in suspension and on surfaces. Product B (hydrogen peroxide) was not effective in suspension (0.9 log(10) after 15 min; 3.2 log(10) after 1 h) and on surfaces (2.8 log(10) after 15 and 60 min). Product E based on glutaraldehyde, (ethylendioxy)dimethanol and DDAC demonstrated 0.9 log(10) after 4 h in suspension and 4.5 log(10) after 4 h on surfaces. Conclusions: Not all surface disinfectants with a sporicidal claim were effective against C. difficile spores in standardized suspension tests and in the 4-field test. In clinical practice preference should be given to products that reliably pass the efficacy criteria of both types of tests. (C) 2022 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据